The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...

Dear Dr. Roach: My husband and I have started taking Zepbound for various medical reasons. The medication has significantly ...

Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: My husband and I have started taking Zepbound for various medical reasons. The medication has significantly ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...

Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...